About us

Cathay Health is dedicated to investing in companies at the convergence of life sciences, healthcare and technology with positive impact on human health.

With a reach spanning key bio and tech hubs around the globe, we help companies scale across borders and access new markets, partners and patients.

San Francisco – New York – London – Cambridge – Paris – Basel – Shanghai

Our Strategy
We back venture- and growth-stage companies
with emerging technologies that catalyze groundbreaking advances in healthcare.
We fund future leaders in tech-enabled medicine
with differentiated approaches and strong intellectual property to personalize care, improve access and lower cost.
We invest in Series A to C rounds
with the ability to lead or co-invest, and help companies scale across borders

Our Focus Areas

  • Life Science Tools
  • Diagnostics
  • Clinical Trial Innovation
  • New Care Models
  • Novel Devices & Materials
  • Enabling Technologies For Advanced Therapies
Why Cathay Health
A global platform catalyzing cross-industry collaboration
Cathay Health is affiliated to Cathay Capital – a global investment platform connecting partners and catalyzing collaborations across Europe, North America and Asia to solve the world’s most pressing challenges.
Scaling companies to transform health across borders
Our global network and operating expertise across regions allows us to grow impactful companies that serve patients worldwide.
Deep expertise in both healthcare and technology
Our unique expertise allows us to identify investment opportunities with the largest impact on human health and care.

Meet Our Team

Investing & operating at the convergence

Our team not only invests – but brings operating experience – at the convergence of life sciences, healthcare and tech. Our expertise uniquely bridges these complementary fields to maximize the potential of our portfolio companies.

Ming-Po Cai

Founder, Chairman & CEO
Cathay Capital

Hongjie Hu

Co-founder & Managing Partner
Cathay Health
New York & Paris

Eric de La Fortelle

Managing Partner

Cathay Health

Paris & Basel

Jia-Yi Har


Cathay Health

London & Paris

Stephen Oesterle

Venture Partner

Cathay Health


Our Portfolio Companies

Specialist CDMO serving gene and cell therapy developers


Biomorphic programmable polymers enabling atraumatic tissue repair


Next generation co-manipulation surgical robots for soft tissue surgeries


Pre-clinical biotech developing drugs targeting the ferroptosis pathway


Robotic assistance technologies for orthopedic surgeries


Venture studio creating tomorrow’s health tech solutions